ReviewImmunotherapy advances2022
Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer.
Rafaela Rossetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it